Search - tctmd.com

Displaying 161 - 180 of 602

Sort: Relevancy | Date

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

TWIST Pipeline

Presenter: NULL

October 25, 2023

Presentation TCT 2023

How it Started… How it’s Going. CONFORMAL EFS Clinical Data & CONFORM Trial Update

Presenter: William Gray

October 25, 2023

Presentation TCT 2023

LV positive reverse remodeling in the TWIST study

Presenter: Ehud Schwammenthal

October 25, 2023

Presentation TCT 2023

TWIST study clinical data

Presenter: Samir Kapadia

October 25, 2023

Presentation TCT 2023

TWIST Live case

Presenter: Chet Rihal

October 25, 2023

Presentation TCT 2023

TWIST TMVR technology overview

Presenter: Ehud Raanani

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2023

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

Presenter: Jayakumar Sreenivasan

October 24, 2023

Presentation TCT 2023

TCT 598: Hemodynamic Assessment of Suboptimal Percutaneous Coronary Intervention outcomes using coronary intravascular imaging based ultrasonic flow ratio and optical flow ratio: Insights from ASET JAPAN Trial

Presenter: Pruthvi Chenniganahosahalli Revaiah

October 24, 2023

Presentation TCT 2023

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Presenter: Omar Khalique

October 24, 2023

Presentation TCT 2023

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Presenter: Nadira Hamid

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Advertisement

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

TWIST Pipeline

How it Started… How it’s Going. CONFORMAL EFS Clinical Data & CONFORM Trial Update

LV positive reverse remodeling in the TWIST study

TWIST study clinical data

TWIST Live case

TWIST TMVR technology overview

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Are Outcome Trials Necessary for Renal Denervation Therapies?

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

What Will the Next Trial Designs Look Like for Renal Denervation?

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

TCT 598: Hemodynamic Assessment of Suboptimal Percutaneous Coronary Intervention outcomes using coronary intravascular imaging based ultrasonic flow ratio and optical flow ratio: Insights from ASET JAPAN Trial

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Trialist Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content